Modeling cancer patient populations in mice: Complex genetic and environmental factors

Drug Discovery Today: Disease Models

Volumn 4, Issue 2, 2007, Pages 83-88

  Radiloff, Daniel R ^a   Rinella, Erica S ^b   Threadgill, David W ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER MODEL; CANCER PATIENT; CARCINOGENESIS; DIET; DRUG EFFICACY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; NONHUMAN; NUTRITION; POPULATION RESEARCH; PREDICTION; REVIEW; TOXICITY TESTING; TUMOR XENOGRAFT;

EID: 40949104048     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.06.004     Document Type: Review

References (36)

1. Chatterjee R. Cell biology. Cases of mistaken identity. Science 315 (2007) 928-931
2. Garber K. Realistic rodents? Debate grows over new mouse models of cancer. J. Natl. Cancer Inst. 98 (2006) 1176-1178
3. Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 149 (2004) 76-88
4. Stewart T.A., et al. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38 (1984) 627-637
5. Quaife C.J., et al. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48 (1987) 1023-1034
6. Jacks T., et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4 (1994) 1-7
7. Jacks T., et al. Effects of an Rb mutation in the mouse. Nature 359 (1992) 295-300
8. Donehower L.A., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356 (1992) 215-221
9. Marshall E. Intellectual property. DuPont ups ante on use of Harvard's OncoMouse. Science 296 (2002) 1212
10. Shorett P. Of transgenic mice and men. GeneWatch 15 (2002) 5
11. Aguirre A.J., et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17 (2003) 3112-3126
12. Mao J.H., and Balmain A. Genomic approaches to identification of tumor-susceptibility genes using mouse models. Curr. Opin. Genet. Dev. 13 (2003) 14-19
13. Nagase H., et al. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 15032-15037
14. Malkinson A.M., et al. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 23 (2002) 411-417
15. Wang D., et al. Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in mice. Oncogene 21 (2002) 6858-6865
16. Festing M.F., et al. Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food Chem. Toxicol. 39 (2001) 375-383
17. Gariboldi M., et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet. 3 (1993) 132-136
18. To M.D., et al. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat. Genet. 38 (2006) 926-930
19. Danaei G., et al. Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors. Lancet 366 (2005) 1784-1793
20. Xue L., et al. Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J. Natl. Cancer Inst. 91 (1999) 176-181
21. Newmark H.L., et al. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J. Natl. Cancer Inst. 82 (1990) 491-496
22. Newmark H.L., et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 22 (2001) 1871-1875
23. Yang W., et al. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. Cancer Res. 63 (2003) 4990-4996
24. Radimer K., et al. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am. J. Epidemiol. 160 (2004) 339-349
25. Werneke U., et al. Potential health risks of complementary alternative medicines in cancer patients. Br. J. Cancer 90 (2004) 408-413
26. Aggarwal B.B., and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71 (2006) 1397-1421
27. Curtin K., et al. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 285-292
28. Shrubsole M.J., et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 190-196
29. Slattery M.L., et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int. J. Cancer 111 (2004) 750-756
30. Weiss W.A., et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene 21 (2002) 7453-7463
31. Reilly K.M., et al. Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat. Genet 26 (2000) 109-113
32. Cardiff R.D., et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19 (2000) 968-988
33. Boivin G.P., et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124 (2003) 762-777
34. Nikitin A.Y., et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res. 64 (2004) 2307-2316
35. Kim C.F., et al. Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb. Symp. Quant. Biol. 70 (2005) 241-250
36. Kasper S. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis. J. Cell Biochem. 94 (2005) 279-297